284 related articles for article (PubMed ID: 9110069)
21. Specific immune response to human immunodeficiency virus (HIV)-1 in patients assessed through the production of interferon-gamma and interleukin-4 in HIV-1 p24-activated whole blood cultures: relationship with the viral load in plasma.
Hober D; Benyoucef S; Chieux V; De Groote D; De La Tribonnière X; Bocket L; Lion G; Mouton Y; Wattré P
Scand J Immunol; 1999 Jul; 50(1):83-90. PubMed ID: 10404056
[TBL] [Abstract][Full Text] [Related]
22. Elevated CD8+DR+ lymphocytes in HIV-exposed infants with early positive HIV cultures: a possible early marker of intrauterine transmission. Women and Infants Transmission Study Group.
Rich KC; Chang BH; Mofenson L; Fowler MG; Cooper E; Pitt J; Hillyer GV; Mendez H
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):204-10. PubMed ID: 9257655
[TBL] [Abstract][Full Text] [Related]
23. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
24. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
Bernard NF; Pederson K; Chung F; Ouellet L; Wainberg MA; Tsoukas CM
AIDS; 1998 Nov; 12(16):2125-39. PubMed ID: 9833853
[TBL] [Abstract][Full Text] [Related]
25. Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects.
Rubbert A; Weissman D; Combadiere C; Pettrone KA; Daucher JA; Murphy PM; Fauci AS
AIDS Res Hum Retroviruses; 1997 Jan; 13(1):63-9. PubMed ID: 8989428
[TBL] [Abstract][Full Text] [Related]
26. Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression.
Dalod M; Fiorentino S; Delamare C; Rouzioux C; Sicard D; Guillet JG; Gomard E
AIDS Res Hum Retroviruses; 1996 Apr; 12(6):497-506. PubMed ID: 8679305
[TBL] [Abstract][Full Text] [Related]
27. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
28. Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells.
Buckheit RW; Siliciano RF; Blankson JN
Retrovirology; 2013 Jul; 10():68. PubMed ID: 23816179
[TBL] [Abstract][Full Text] [Related]
29. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
[TBL] [Abstract][Full Text] [Related]
30. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
[TBL] [Abstract][Full Text] [Related]
31. HIV Replication Is Not Controlled by CD8+ T Cells during the Acute Phase of the Infection in Humanized Mice.
Petit NY; Lambert-Niclot S; Marcelin AG; Garcia S; Marodon G
PLoS One; 2015; 10(9):e0138420. PubMed ID: 26407077
[TBL] [Abstract][Full Text] [Related]
32. Suppression of HIV replication in vitro by CD8+ T-cells from HIV-infected and HIV-seronegative individuals.
Tsuchie H; Detorio MA; Hossain MM; Tesfamariam N; Trickett A; Lam-Po-Tang PR; Yamada O; Ichimura H; Dwyer JM; Kurimura T
Int J STD AIDS; 1997 May; 8(5):307-10. PubMed ID: 9175652
[TBL] [Abstract][Full Text] [Related]
33. Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.
Slichter CK; Friedrich DP; Smith RJ; Walsh PN; Mize G; Czartoski JL; McElrath MJ; Frahm N
J Immunol Methods; 2014 Feb; 404():71-80. PubMed ID: 24374374
[TBL] [Abstract][Full Text] [Related]
34. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment.
Sandberg JK; Fast NM; Jordan KA; Furlan SN; Barbour JD; Fennelly G; Dobroszycki J; Spiegel HM; Wiznia A; Rosenberg MG; Nixon DF
J Immunol; 2003 Apr; 170(8):4403-10. PubMed ID: 12682278
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1-infected patients: relative balance between host immune response and the spread of HIV type 1 infection.
Bariou C; Genetet N; Ruffault A; Michelet C; Cartier F; Genetet B
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1301-12. PubMed ID: 9339847
[TBL] [Abstract][Full Text] [Related]
36. Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.
Johnson S; Eller M; Teigler JE; Maloveste SM; Schultz BT; Soghoian DZ; Lu R; Oster AF; Chenine AL; Alter G; Dittmer U; Marovich M; Robb ML; Michael NL; Bolton D; Streeck H
J Virol; 2015 Aug; 89(15):7494-505. PubMed ID: 25972560
[TBL] [Abstract][Full Text] [Related]
37. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
[TBL] [Abstract][Full Text] [Related]
38. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
Luzuriaga K; Koup RA; Pikora CA; Brettler DB; Sullivan JL
J Pediatr; 1991 Aug; 119(2):230-6. PubMed ID: 1907319
[TBL] [Abstract][Full Text] [Related]
39. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV+ patients: flow cytometric analysis.
Yamamura Y; Rodriguez N; Schwartz A; Eylar E; Yano N
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S133-44. PubMed ID: 8574141
[TBL] [Abstract][Full Text] [Related]
40. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.
Sáez-Cirión A; Lacabaratz C; Lambotte O; Versmisse P; Urrutia A; Boufassa F; Barré-Sinoussi F; Delfraissy JF; Sinet M; Pancino G; Venet A;
Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6776-81. PubMed ID: 17428922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
